ESOC 2024 | How does remote ischemic conditioning improve outcomes?

Francisco Purroy, PhD, Institut de Recerca Biomèdica de Lleida, Leida, Spain, shares his thoughts on the potential mechanisms by which remote ischemic perconditioning (RIPerC) may improve outcomes in acute ischemic stroke patients. The REMOTE-CAT trial randomized patients to five cycles of RIPerC or sham stimulation. Based on the finding that benefit was seen in those without large vessel occlusion, Dr Purroy hypothesizes that RIPerC prevents reperfusion injury in those who achieve recanalization during hospital transport. This interview took place at the 10th European Stroke Organisation Conference (ESOC) 2024 in Basel, Switzerland.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.